The use of sublingual buprenorphine-naloxone for reversing heroin overdose: a high-risk strategy that should not be recommended.
Nielsen
Suzanne
S
Lintzeris
Nicholas
N
D002047:Buprenorphine / Q000009:adverse effects*; D004338:Drug Combinations; D062787:Drug Overdose / Q000188:drug therapy; D003932:Heroin / Q000506:poisoning*; D006801:Humans; D009270:Naloxone / Q000009:adverse effects*; D009292:Narcotic Antagonists / Q000009:adverse effects*; D009294:Narcotics / Q000506:poisoning*; D015819:Substance Abuse, Intravenous / Q000150:complications*
D004338:Drug Combinations; D009292:Narcotic Antagonists; D009294:Narcotics; D009270:Naloxone; D002047:Buprenorphine; D003932:Heroin